Ftse Mib
34.035,87
-0,99%
DAX
18.468,11
-0,71%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.810,91
-3,15%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Processa Pharmaceuticals Inc (PCSA) Processa Pharmaceuticals Inc (PCSA) Notizie

PCSA

Processa Pharmaceuticals (PCSA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PCSA
DataOraFonteTitoloSimboloCompagnia
27/07/202114:30GlobeNewswire Inc.Processa Pharmaceuticals to Present at “Zooming with LD Micro” Virtual Investor Event on July 29, 2021 at 12:00 p.m. ETNASDAQ:PCSAProcessa Pharmaceuticals Inc
15/07/202115:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
12/07/202112:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/07/202122:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
06/07/202114:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at Access to Giving Virtual Conference on July 14, 2021 at 10:30 a.m. ETNASDAQ:PCSAProcessa Pharmaceuticals Inc
30/06/202122:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PCSAProcessa Pharmaceuticals Inc
17/06/202115:15GlobeNewswire Inc.PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR THE DEVELOPMENT OF RX-3117NASDAQ:PCSAProcessa Pharmaceuticals Inc
08/06/202115:15GlobeNewswire Inc.Processa Set to Join Russell Microcap® IndexNASDAQ:PCSAProcessa Pharmaceuticals Inc
07/06/202122:05GlobeNewswire Inc.Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ETNASDAQ:PCSAProcessa Pharmaceuticals Inc
26/05/202115:15GlobeNewswire Inc.Processa Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:PCSAProcessa Pharmaceuticals Inc
20/05/202122:05GlobeNewswire Inc.Processa Pharmaceuticals Announces First Patient Dosed in its Randomized Double-Blind, Placebo-Controlled Clinical Trial to E...NASDAQ:PCSAProcessa Pharmaceuticals Inc
13/05/202122:55GlobeNewswire Inc.Processa Pharmaceuticals Announces First Quarter 2021 Results and Provides Corporate UpdateNASDAQ:PCSAProcessa Pharmaceuticals Inc
07/05/202114:30GlobeNewswire Inc.Processa Pharmaceuticals Schedules Conference Call to Discuss First Quarter Results and Provide Drug Development Update on Ma...NASDAQ:PCSAProcessa Pharmaceuticals Inc
05/05/202118:54Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
26/04/202122:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
22/04/202120:00Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
12/04/202119:45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PCSAProcessa Pharmaceuticals Inc
08/04/202123:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
07/04/202122:24Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
26/03/202100:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
25/03/202121:06GlobeNewswire Inc.Processa Pharmaceuticals Announces Year end 2020 Results and Provides Corporate UpdateNASDAQ:PCSAProcessa Pharmaceuticals Inc
22/03/202114:15GlobeNewswire Inc.Processa Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter Results and Provide Drug Development Update on M...NASDAQ:PCSAProcessa Pharmaceuticals Inc
17/03/202114:15GlobeNewswire Inc.Processa Announces Sites Selected for Phase 2B Clinical Trial to Treat Patients with Ulcerated Necrobiosis LipoidicaNASDAQ:PCSAProcessa Pharmaceuticals Inc
02/03/202115:15GlobeNewswire Inc.Processa Pharmaceuticals Announces Closing of a $10.2 Million Private PlacementNASDAQ:PCSAProcessa Pharmaceuticals Inc
19/02/202115:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PCSAProcessa Pharmaceuticals Inc
17/02/202114:00GlobeNewswire Inc.Processa Pharmaceuticals Announces $10.2 Million Strategic FinancingNASDAQ:PCSAProcessa Pharmaceuticals Inc
11/01/202116:50GlobeNewswire Inc.Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
13/11/202022:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PCSAProcessa Pharmaceuticals Inc
12/11/202023:01GlobeNewswire Inc.Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate UpdateNASDAQ:PCSAProcessa Pharmaceuticals Inc
12/11/202022:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCSAProcessa Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PCSA

La tua Cronologia

LSE
ORP
LSE
FCSS
Fidelity China Special S...
NASDAQ
CG
Carlyle
LSE
ITV
Itv
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network